Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics

Published on 5 May 2021

European Commission Press release Brussels, 06 May 2021 The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'.

Continue reading on website
Other news

Handbook and appendix on Nature Based Solutions (NBS)

5 May 2021
The Directorate-General for Research and Innovation (European Commission) published, on the 4th of May 2021, the "Handbook and appendix on Nature Based Solutions (NBS)".The Handbook aims to provide decision-makers with a comprehensive NBS impact assessment framework, and a robust set of indicators and methodologies to assess impacts of nature-based solutions across 12 societal challenge areas: Cli

EU's local and regional leaders call for patent waiver on COVID-19 vaccines

6 May 2021
The European Committee of the Regions has called on the European Union to temporarily waive patents for vaccines against the COVID-19 virus, in order to curb the rapid spread of the pandemic. It also pressed for production in Europe to be increased and for an acceleration in the vaccination campaign across Europe.